Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.

Xing HuangGang ZhangTianyu TangTingbo Liang

Published in: Molecular cancer (2021)

ADAM9, EFNB2, MET, TMOD3, TPX2, and WNT7A are potent antigens for developing anti-PAAD mRNA vaccine, and patients with IS4 and IS5 tumors are suitable for vaccination.

Keyphrases

dendritic cells
binding protein
stem cells
cell proliferation
tyrosine kinase
anti inflammatory
immune response